One study on semaglutide reported an average 6-months weight loss of approximately 11.5 kg (roughly 10%15% of baseline weight) and observed a high proportion of improvement in menstrual cycles ( In clinical practice, weight losses of 5% and 10% are commonly used thresholds for clinical significance. PCOS guidelines state that a weight reduction of 5% can significantly improve insulin sensitivity and hyperandrogenic load, while 10% weight loss is strongly linked to restored ovulation and improved pregnancy rates (78)
Understanding the correct method of administration is crucial to maximising therapeutic benefit and minimising adverse effects
But beneath the high-tech presentation lies a problematic combination of: Unsubstantiated medical claims No verifiable clinical data or regulatory approval Emotional marketing using fake endorsements Pricing tactics designed to rush purchases This raises strong doubt about legitimacythough it stops short of calling it outright fraudulent, the apparent misdirection and lack of transparency warrant caution
Supports Steadier Hydration and Blood Pressure: Many patients find their bodies hold water more evenly, decreasing sudden spikes in blood pressure
He doesnt believe in a one-size-fits-all approach
FDA relies on the complete, accurate, and timely submission of ADEs to monitor a products safety profile and uphold FDAs mission to protect and promote public health, the FDA wrote, referring to adverse drug events. It said findings were based on an inspection of a Novo Nordisk facility in New Jersey last year